Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  NASDAQ OMX COPENHAGEN  >  Genmab A/S    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
Fonds positionnés sur GENMAB A/S
NomPEA1er Jan5 ansNotationPosition
UBS (Lux) EF Biotech (USD) P-accNON-9.00%-12.00%34.66M USD


ETFs positionnés sur GENMAB A/SETFs et Trackers avec Trackinsight
ETFVar. 5jours PoidsRatingZone géographiqueCatégorie et Secteur
Deka STOXX Europe Strong Growth 20 ...4.95%5.66%EuropeActions
Deka STOXX Europe Strong Style Comp...3.83%2.86%EuropeActions
Xtrackers MSCI Nordic 1D - EUR9.12%1.59%NordiqueActions
SPDR MSCI Europe Health Care - EUR8.47%1.11%EuropeActions - Santé
IShares STOXX Europe 600 Health Car...1.25%1.00%EuropeActions - Santé
Deka MSCI Europe MC - EUR7.94%0.74%EuropeActions
Deka MSCI Europe ex EMU - EUR7.89%0.32%EuropeActions
SPDR MSCI World Health Care - USD4.46%0.25%MondeActions - Santé
IShares Global Healthcare ETF - USD3.59%0.23%MondeActions - Santé
BNP Paribas Easy MSCI Europe ex UK ...3.97%0.21%EuropeActions
Vanguard FTSE Developed Europe ex U...0.51%0.20%EuropeActions
IShares STOXX Europe Large 200 (DE...8.42%0.18%EuropeActions
Franklin FTSE Europe ex U.K. Index ...9.72%0.17%-EuropeActions
UBS ETF - MSCI Europe A-dis - EUR4.56%0.16%EuropeActions
UBS ETF (LU) MSCI Europe (hedged t...4.92%0.16%-EuropeActions
UBS ETF - MSCI Europe (hedged to U...7.17%0.16%-EuropeActions
UBS ETF (LU) MSCI Europe (hedged t...-0.34%0.16%-EuropeActions
Xtrackers MSCI Europe 2C (USD Hedg...5.56%0.16%-EuropeActions
BNP Paribas Easy MSCI Europe ex CW ...5.33%0.15%EuropeActions
Lyxor MSCI Europe - Dist - EUR6.53%0.15%EuropeActions
1  2Suiv.



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique GENMAB A/S
Durée : Période :
Genmab A/S : Graphique analyse technique Genmab A/S | Zone bourse
Graphique plein écran
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne ACCUMULER
Nombre d'Analystes 20
Objectif de cours Moyen 1 658,21  DKK
Dernier Cours de Cloture 1 377,00  DKK
Ecart / Objectif Haut 43,9%
Ecart / Objectif Moyen 20,4%
Ecart / Objectif Bas -32,5%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapitalisation (M$)
GENMAB A/S-7.05%13 229
GILEAD SCIENCES15.05%95 597
VERTEX PHARMACEUTICALS8.68%60 130
REGENERON PHARMACEUTICALS30.04%51 490
WUXI APPTEC CO., LTD.-5.02%20 264
BEIGENE, LTD.-25.73%9 729